Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Håvar Knutsen"'
Autor:
Claus Henrik Nielsen, Christian Enevold, Ole Birger Pedersen, Waleed Ghanima, Anders Lindholm Sørensen, Håvar Knutsen, Gunnar Birgegård, Hans Carl Hasselbalch, Bjorn Andreasson, Elisabeth Ejerblad, Erik Ahlstrand, Jan Samuelsson
Publikováno v:
European Journal of Haematology. 102:235-240
OBJECTIVES The study investigates the hypothesis that inflammation in myelofibrosis (MF) like in myeloma and lymphoma, may disturb iron distribution and contribute to anaemia. METHODS A cross-sectional study of 80 MF and 23 ET patients was performed.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3e9ac606f26ad3ed107788c8c2f9c6b
https://doi.org/10.1111/ejh.13198
https://doi.org/10.1111/ejh.13198
Autor:
Jan Samuelsson, Håvar Knutsen, Lennart Nilsson, Bjorn Andreasson, Waleed Ghanima, Johan Westin, Marie Lindgren, P. Johansson
Publikováno v:
European journal of haematology. 100(5)
Objective In myeloproliferative neoplasms (MPN), interferon-alpha (IFN-α) is an effective treatment with disease-modifying properties but currently with no clear predictors of treatment outcome. Recent genomewide association studies in chronic hepat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d5789266faf78e95b625ee5033f8ccc
https://pubmed.ncbi.nlm.nih.gov/29369421
https://pubmed.ncbi.nlm.nih.gov/29369421
Publikováno v:
Tidsskrift for Den norske legeforening. 133:1946-1950
Background Primary myelofibrosis is a malignant myeloproliferative disease. It is characterised by proliferation of megakaryocytes in the bone marrow, dysregulated cytokine production and reactive fibrosis that causes bone marrow failure. The purpose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2d0fd228853a212577073f145f999cb
https://doi.org/10.4045/tidsskr.12.1106
https://doi.org/10.4045/tidsskr.12.1106
Autor:
Martin Höglund, C. Michel Zwaan, Henrik Hjorth-Hansen, Rafael F. Duarte, Kimmo Porkka, Suhag Parikh, Benoit Brethon, Robert A. Wild, Satu Mustjoki, Håvar Knutsen, Tuija Lundán, Erkki Elonen, Hervé Dombret, Finella Brito-Babapulle, Hana Klamova, Lydia Eccersley, Montserrat Arnan, Roger Luo, Richard Smykla, Johanna Rimpiläinen, Franz Gruber, Ron Paquette, Emmanuel Raffoux, Perttu Koskenvesa, Francis Y. Lee
Publikováno v:
Blood, 112(4), 1005-1012. American Society of Hematology
Although imatinib, a BCR-ABL tyrosine kinase inhibitor, is used to treat acute Philadelphia chromosome–positive (Ph+) leukemia, it does not prevent central nervous system (CNS) relapses resulting from poor drug penetration through the blood-brain b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ceedc511a7965b3b88d994b5223378f
https://pure.eur.nl/en/publications/13a0aaaf-c56a-4ff5-893d-cc0e4742a4ad
https://pure.eur.nl/en/publications/13a0aaaf-c56a-4ff5-893d-cc0e4742a4ad
Publikováno v:
European journal of haematology. 94(2)
Several studies have reported an increased incidence of coexistent cancer in patients with myeloproliferative neoplasms (MPN), and myelosuppressive treatment has been speculated to be one of the causes. In this study, we have concentrated on malignan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c304d4fe72830d7a6b750d6f96fb982e
https://pubmed.ncbi.nlm.nih.gov/25689636
https://pubmed.ncbi.nlm.nih.gov/25689636
Autor:
Bjorn Andreasson, Anna Hugosson, Lennart Nilsson, Håvar Knutsen, Marie Lindgren, Elisabeth Ejerblad, P. Johansson, Maria Åström, Jan Samuelsson, Waleed Ghanima
Publikováno v:
Blood. 124:1861-1861
Background In myeloproliferative neoplasms (MPN), Interferon-α (IFN-α) has been shown effective in inducing hematologic and molecular responses and in reducing vascular events. In clinical practice its use is mainly limited by intolerance due to si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8c4f9c2517605a889bdda63e18ba2de
https://doi.org/10.1182/blood.v124.21.1861.1861
https://doi.org/10.1182/blood.v124.21.1861.1861
Autor:
Fuad Victor Shammas, Elling Ulvestad, Sigbjørn Berentsen, Håvar Knutsen, Henrik Hjorth-Hansen, Ruth Langholm, Waleed Ghanima, Geir E. Tjønnfjord, Bjørn Tore Gjertsen
Publikováno v:
Blood. 103(8)
Conventional therapies for primary chronic cold agglutinin disease (CAD) are ineffective, but remissions after treatment with the anti-CD20 antibody rituximab have been described in a small, prospective trial and in some case reports. In this study w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4148e8cc9a7199b4ff6172ff92205130
https://pubmed.ncbi.nlm.nih.gov/15070665
https://pubmed.ncbi.nlm.nih.gov/15070665
Autor:
Håvar Knutsen
Publikováno v:
Mayo Clinic Proceedings. 79:430
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14baf7324481ad1f37537db3d3f68a3b
https://doi.org/10.4065/79.3.430
https://doi.org/10.4065/79.3.430
Publikováno v:
Alcoholism, clinical and experimental research. 13(3)
The effect of ethanol [1 g/kg per orally (p.o.) during 1 hr] after thyrotropin-releasing hormone (TRH) pretreatment (five doses of 20 mg p.o. during 30 hr preceeding ethanol intake) was studied in a placebo-controlled, double-blind design in 11 healt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3de42a7625a9d336952a63bd1ce97f52
https://pubmed.ncbi.nlm.nih.gov/2502040
https://pubmed.ncbi.nlm.nih.gov/2502040